These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Stopping the rise of myopia in Asia. Spillmann L. Graefes Arch Clin Exp Ophthalmol; 2020 May; 258(5):943-959. PubMed ID: 31873785 [Abstract] [Full Text] [Related]
25. Evaluating the myopia progression control efficacy of defocus incorporated multiple segments (DIMS) lenses and Apollo progressive addition spectacle lenses (PALs) in 6- to 12-year-old children: study protocol for a prospective, multicenter, randomized controlled trial. Li Y, Fu Y, Wang K, Liu Z, Shi X, Zhao M. Trials; 2020 Mar 19; 21(1):279. PubMed ID: 32188478 [Abstract] [Full Text] [Related]
27. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control. Yam JC, Jiang Y, Tang SM, Law AKP, Chan JJ, Wong E, Ko ST, Young AL, Tham CC, Chen LJ, Pang CP. Ophthalmology; 2019 Jan 19; 126(1):113-124. PubMed ID: 30514630 [Abstract] [Full Text] [Related]
35. Progression of myopia in Hong Kong Chinese schoolchildren is slowed by wearing progressive lenses. Leung JT, Brown B. Optom Vis Sci; 1999 Jun 01; 76(6):346-54. PubMed ID: 10416928 [Abstract] [Full Text] [Related]
36. Advances in myopia control strategies for children. Zhang XJ, Zaabaar E, French AN, Tang FY, Kam KW, Tham CC, Chen LJ, Pang CP, Yam JC. Br J Ophthalmol; 2024 May 22. PubMed ID: 38777389 [Abstract] [Full Text] [Related]